Ruediger Naumann-Etienne - 09 Feb 2023 Form 4 Insider Report for Varex Imaging Corp (VREX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
13 Feb 2023, 16:25:48 UTC
Prior SEC filing
09 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kimberley Honeysett, attorney-in-fact for Ruediger Naumann-Etienne

Key filing fact

Ruediger Naumann-Etienne filed Form 4 for Varex Imaging Corp (VREX) on 13 Feb 2023.

Key facts

  • This page summarizes Ruediger Naumann-Etienne's Form 4 filing for Varex Imaging Corp (VREX).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 13 Feb 2023, 16:25.

Change

  • Previous filing in this sequence was filed on 09 Nov 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VREX transaction

Common Stock

Options Exercise

Transaction value
Shares
+8,471
Change %
+40%
Price
Shares after
29,846
Date
09 Feb 2023
Ownership
Direct
Footnotes
F1
VREX transaction

Common Stock

Options Exercise

Transaction value
Shares
+9,462
Change %
+32%
Price
Shares after
39,308
Date
09 Feb 2023
Ownership
Direct
Footnotes
F1
VREX transaction

Common Stock

Options Exercise

Transaction value
Shares
+9,038
Change %
+23%
Price
Shares after
48,346
Date
09 Feb 2023
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VREX transaction Derivative

Deferred Stock Units

Options Exercise

Transaction value
$0
Shares
-8,471
Change %
-100%
Price
$0.000000*
Shares after
0
Date
09 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,471
Exercise price
Footnotes
F1, F2
VREX transaction Derivative

Deferred Stock Units

Options Exercise

Transaction value
$0
Shares
-9,462
Change %
-100%
Price
$0.000000*
Shares after
0
Date
09 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,462
Exercise price
Footnotes
F1, F3
VREX transaction Derivative

Deferred Stock Units

Options Exercise

Transaction value
$0
Shares
-9,038
Change %
-100%
Price
$0.000000*
Shares after
0
Date
09 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,038
Exercise price
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Ruediger Naumann-Etienne is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 4 footnotes

Footnote F1

Each Deferred Stock Unit converts into common stock on a one-for-one basis.

Footnote F2

These Deferred Stock Units vested on February 13, 2021. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer.

Footnote F3

These Deferred Stock Units vested on February 10, 2022. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer.

Footnote F4

These Deferred Stock Units vested on February 9, 2023. Pursuant to the terms of the applicable grant agreement, delivery of the vested Deferred Stock Units, in the form of common stock, was made on February 9, 2023 in connection with the reporting person's retirement from the board of directors of the issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .